Innovex sees Q3 revenue $230M-$240M, one estimate $227M

Sees Q3 adjusted EBITDA $40M-$45M. The company said, “Even after acquiring Citadel on May 30th in an all-cash $70 million transaction, we continue to maintain a net-cash balance sheet. The acquisition was highly accretive even before expected synergies and demonstrates strong transaction-level returns. Citadel was purchased at a valuation of 3.8x LTM Adjusted EBITDA and was 8% accretive to Innovex’s (INVX) EPS. Importantly, we are still targeting a Q3 2025 close on the sale of the Eldridge facility, which will further enhance our net cash position. Despite a decline in revenue, our capital-light business model enabled us to maintain margins and increase free cash flow, demonstrating the counter-cyclical cash flow profile of our businesses.”.